CRH Plc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), CRH Plc reported revenue of $37.4B (+5.3% year on year) and net income of $3.8B (+7.5% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Total revenues | $37.4B | $35.6B | $34.9B | — |
| Total cost of revenues | ($23.9B) | ($22.9B) | ($23.0B) | — |
| Gross (loss) profit | $13.5B | $12.7B | $12.0B | — |
| Selling, general and administrative expenses | ($8.3B) | ($7.9B) | ($7.5B) | — |
| Gain on disposal of long-lived assets | $235.0M | $237.0M | $66.0M | — |
| Loss on impairments | ($40.0M) | ($161.0M) | ($357.0M) | — |
| Operating income | $5.4B | $4.9B | $4.2B | — |
| Interest income | $146.0M | $143.0M | $206.0M | — |
| Interest expense | ($810.0M) | ($612.0M) | ($376.0M) | — |
| Other nonoperating income (expense), net | $29.0M | $258.0M | ($2.0M) | — |
| Income before income tax expense and income from equity method investments | $4.8B | $4.7B | $4.0B | — |
| Income tax expense | ($1.0B) | ($1.1B) | ($925.0M) | ($785.0M) |
| Income (loss) from equity method investments | $26.0M | ($108.0M) | ($17.0M) | — |
| Income from continuing operations | $3.8B | $3.5B | $3.1B | — |
| Net (income) attributable to redeemable noncontrolling interests | ($28.0M) | ($28.0M) | ($28.0M) | — |
| Net (income) loss attributable to noncontrolling interests | ($9.0M) | ($1.0M) | $134.0M | — |
| Net income attributable to CRH | $3.8B | $3.5B | $3.2B | — |
| Basic earnings per share attributable to CRH plc, net income (in USD per share) | $5.54 | $5.06 | $4.36 | — |
| Diluted earnings per share, net income (in USD per share) | $5.51 | $5.02 | $4.33 | — |
| Weighted average common shares outstanding, basic (in shares) | 673.2M | 683.3M | 723.9M | — |
| Weighted average common shares outstanding, diluted (in shares) | 677.0M | 689.5M | 729.2M | — |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Total revenues | $10.8B | $7.4B | $11.1B | $10.2B |
| Total cost of revenues | ($6.5B) | ($5.3B) | ($6.8B) | ($6.2B) |
| Gross profit | $4.3B | $2.0B | $4.3B | $4.0B |
| Selling, general and administrative expenses | ($2.3B) | ($2.1B) | ($2.3B) | ($2.1B) |
| Gain on disposal of long-lived assets | $52.0M | $22.0M | $110.0M | $29.0M |
| Loss on impairments | $0 | ($48.0M) | — | — |
| Operating income | $2.1B | ($38.0M) | $2.1B | $1.9B |
| Interest income | $22.0M | $21.0M | $37.0M | $30.0M |
| Interest expense | ($220.0M) | ($203.0M) | ($209.0M) | ($200.0M) |
| Other nonoperating income (expense), net | $282.0M | ($4.0M) | $12.0M | ($9.0M) |
| Income from operations before income tax expense and income from equity method investments | $2.2B | ($224.0M) | $1.9B | $1.8B |
| Income tax expense | ($661.0M) | $55.0M | ($428.0M) | ($425.0M) |
| Income (loss) from equity method investments | $9.0M | ($11.0M) | $26.0M | $1.0M |
| Net income | $1.5B | ($180.0M) | $1.5B | $1.3B |
| Net (income) attributable to redeemable noncontrolling interests | ($10.0M) | — | ($10.0M) | ($8.0M) |
| Net (income) attributable to noncontrolling interests | ($15.0M) | — | ($6.0M) | ($5.0M) |
| Net income attributable to CRH | $1.5B | ($176.0M) | $1.5B | $1.3B |
| Basic (in USD per share) | $2.22 | -$0.27 | $2.23 | $1.95 |
| Diluted (in USD per share) | $2.21 | -$0.27 | $2.21 | $1.94 |
| Basic (in shares) | 667.2M | 668.5M | 672.3M | 674.8M |
| Diluted (in shares) | 668.8M | 668.5M | 675.5M | 677.7M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $4.1B | $3.7B | $6.3B | $5.9B |
| Restricted cash | $51.0M | $39.0M | — | — |
| Accounts receivable, net | $5.2B | $4.8B | $4.5B | — |
| Inventories | $5.3B | $4.8B | $4.3B | $4.2B |
| Other current assets | $678.0M | $749.0M | $478.0M | — |
| Total current assets | $15.3B | $14.1B | $16.9B | $14.8B |
| Property, plant and equipment, net | $24.9B | $21.5B | $17.8B | — |
| Equity method investments | $502.0M | $737.0M | $620.0M | — |
| Goodwill | $13.1B | $11.1B | $9.2B | — |
| Intangible assets, net | $2.0B | $1.2B | $1.0B | — |
| Operating lease right-of-use assets, net | $1.5B | $1.3B | $1.3B | — |
| Other noncurrent assets | $1.0B | $795.0M | $632.0M | — |
| Total assets | $58.3B | $50.6B | $47.5B | $45.2B |
| Accounts payable | $3.3B | $3.2B | $3.1B | — |
| Accrued expenses | $2.2B | $2.2B | $2.3B | — |
| Current portion of long-term debt | $1.2B | $3.0B | $1.9B | — |
| Operating lease liabilities | $286.0M | $265.0M | $255.0M | — |
| Other current liabilities | $1.8B | $1.6B | $2.1B | — |
| Total current liabilities | $8.8B | $10.3B | $10.0B | $8.9B |
| Long-term debt | $16.5B | $11.0B | $9.8B | — |
| Deferred income tax liabilities | $3.5B | $3.1B | $2.7B | $2.9B |
| Noncurrent operating lease liabilities | $1.2B | $1.1B | $1.1B | — |
| Other noncurrent liabilities | $2.9B | $2.3B | $2.2B | — |
| Total liabilities | $32.9B | $27.8B | $25.8B | $22.9B |
| Redeemable noncontrolling interests | $430.0M | $384.0M | $333.0M | — |
| Preferred stock, €1.27 par value, 150,000 shares authorized and 50,000 shares issued and outstanding for 5% preferred stock, and 872,000 shares authorized, issued and outstanding for 7% ‘A’ preferred stock, as of December 31, 2025, and December 31, 2024 | 1.0M | 1.0M | 1.0M | — |
| Common stock, €0.32 par value, 1,250,000,000 shares authorized; 706,946,142 and 718,647,277 shares issued and outstanding, as of December 31, 2025, and December 31, 2024, respectively | 286.0M | 290.0M | 296.0M | — |
| Treasury stock, at cost (38,315,792 and 41,355,384 shares as of December 31, 2025, and December 31, 2024, respectively) | -2.0B | -2.1B | -2.2B | — |
| Additional paid-in capital | $397.0M | $422.0M | $454.0M | — |
| Accumulated other comprehensive loss | ($257.0M) | ($1.0B) | ($616.0M) | — |
| Retained earnings | $25.6B | $24.0B | $22.9B | — |
| Total shareholders’ equity attributable to CRH shareholders | $24.0B | $21.6B | $20.9B | — |
| Noncontrolling interests | $1.0B | $859.0M | $434.0M | — |
| Total equity | $25.0B | $22.5B | $21.3B | $22.3B |
| Total liabilities, redeemable noncontrolling interests and equity | $58.3B | $50.6B | $47.5B | — |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $3.0B | $3.2B | $4.2B | $2.9B |
| Restricted cash | $58.0M | $40.0M | $90.0M | $0 |
| Accounts receivable, net of allowance for credit losses of $136 million, $137 million, and $151 million as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively | $6.8B | $5.2B | $7.0B | $6.5B |
| Inventories | $5.1B | $5.1B | $5.0B | $5.1B |
| Other current assets | $789.0M | $877.0M | $584.0M | $734.0M |
| Total current assets | $15.8B | $16.2B | $16.9B | $15.2B |
| Property, plant and equipment, net | $24.9B | $24.7B | $23.8B | $23.0B |
| Equity method investments | $464.0M | $487.0M | $743.0M | $712.0M |
| Goodwill | $13.2B | $12.6B | $12.7B | $11.7B |
| Intangible assets, net | $2.0B | $2.0B | $2.1B | $1.2B |
| Operating lease right-of-use assets, net | $1.3B | $1.3B | $1.4B | $1.3B |
| Other noncurrent assets | $979.0M | $962.0M | $915.0M | $897.0M |
| Total assets | $58.6B | $58.2B | $58.5B | $54.0B |
| Accounts payable | $3.5B | $2.9B | $3.2B | $3.3B |
| Accrued expenses | $2.0B | $2.1B | $2.4B | $2.3B |
| Current portion of long-term debt | $2.5B | $2.5B | $4.0B | $1.2B |
| Operating lease liabilities | $258.0M | $247.0M | $257.0M | $247.0M |
| Other current liabilities | $1.6B | $2.0B | $1.8B | $1.7B |
| Total current liabilities | $10.0B | $10.2B | $11.6B | $8.7B |
| Long-term debt | $15.4B | $16.1B | $14.7B | $14.6B |
| Deferred income tax liabilities | $3.5B | $3.3B | $3.6B | $3.2B |
| Noncurrent operating lease liabilities | $1.1B | $1.1B | $1.2B | $1.1B |
| Other noncurrent liabilities | $3.1B | $3.0B | $2.8B | $2.7B |
| Total liabilities | $33.0B | $33.6B | $33.9B | $30.4B |
| Redeemable noncontrolling interests | $435.0M | $422.0M | $419.0M | $389.0M |
| Preferred stock, €1.27 par value, nil, 150,000 and 150,000 shares authorized and nil, 50,000 and 50,000 shares issued and outstanding for 5% preferred stock and nil, 872,000 and 872,000 shares authorized, issued and outstanding for 7% 'A' preferred stock, as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively | 0 | 1.0M | 1.0M | 1.0M |
| Common stock, €0.32 par value, 1,250,000,000 shares authorized; 701,490,721, 706,946,142 and 711,792,599 issued and 665,895,636, 668,630,350 and 673,202,797 outstanding, as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively | 284.0M | 285.0M | 287.0M | 288.0M |
| Treasury stock, at cost (35,595,085, 38,315,792 and 38,589,802 shares as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively) | -1.9B | -1.9B | -2.0B | -2.0B |
| Additional paid-in capital | $285.0M | $250.0M | $361.0M | $323.0M |
| Accumulated other comprehensive loss | ($376.0M) | ($353.0M) | ($381.0M) | ($345.0M) |
| Retained earnings | $25.7B | $24.8B | $25.1B | $24.1B |
| Total shareholders’ equity attributable to CRH shareholders | $24.0B | $23.1B | $23.3B | $22.3B |
| Noncontrolling interests | $1.1B | $1.1B | $901.0M | $896.0M |
| Total equity | $25.1B | $24.1B | $24.2B | $23.2B |
| Total liabilities, redeemable noncontrolling interests and equity | $58.6B | $58.2B | $58.5B | $54.0B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $3.8B | $3.5B | $3.1B | — |
| Depreciation, depletion and amortization | $2.2B | $1.8B | $1.6B | — |
| Loss on impairments | $40.0M | $161.0M | $357.0M | — |
| Share-based compensation | $143.0M | $125.0M | $123.0M | — |
| Gains on disposals from businesses and long-lived assets, net | ($247.0M) | — | — | — |
| Deferred tax expense (benefit) | $167.0M | $180.0M | ($64.0M) | — |
| (Income) loss from equity method investments | ($26.0M) | $108.0M | $17.0M | — |
| Pension and other postretirement benefits net periodic benefit cost | $21.0M | $34.0M | $31.0M | — |
| Non-cash operating lease costs | $292.0M | $262.0M | $293.0M | — |
| Other items, net | $3.0M | $14.0M | $68.0M | — |
| Accounts receivable, net | $121.0M | ($122.0M) | ($164.0M) | — |
| Inventories | ($161.0M) | ($224.0M) | ($60.0M) | — |
| Accounts payable | ($158.0M) | $48.0M | $144.0M | — |
| Operating lease liabilities | ($310.0M) | ($287.0M) | ($276.0M) | — |
| Other assets | ($210.0M) | ($69.0M) | $25.0M | — |
| Other liabilities | $45.0M | ($86.0M) | ($72.0M) | — |
| Pension and other postretirement benefits contributions | ($41.0M) | ($43.0M) | ($44.0M) | — |
| Net cash provided by operating activities | $5.6B | $5.0B | $5.0B | — |
| Purchases of property, plant and equipment, and intangibles | ($2.7B) | ($2.6B) | ($1.8B) | — |
| Acquisitions, net of cash acquired | ($3.9B) | ($4.9B) | ($640.0M) | — |
| Proceeds from divestitures | $139.0M | $1.0B | $6.0M | — |
| Proceeds from disposal of long-lived assets | $315.0M | $272.0M | $104.0M | — |
| Dividends received from equity method investments | $50.0M | $44.0M | $44.0M | — |
| Settlements of derivatives | ($81.0M) | ($9.0M) | ($1.0M) | — |
| Deferred divestiture consideration received | $42.0M | $83.0M | — | — |
| Other investing activities, net | $59.0M | ($204.0M) | ($87.0M) | — |
| Net cash used in investing activities | ($6.0B) | ($6.3B) | ($2.4B) | — |
| Proceeds from debt issuances | $10.5B | $4.0B | $3.2B | — |
| Payments on debt | ($7.6B) | ($1.9B) | ($1.5B) | — |
| Settlements of derivatives | $121.0M | ($36.0M) | $7.0M | — |
| Payments of finance lease obligations | ($131.0M) | ($57.0M) | ($26.0M) | — |
| Deferred and contingent acquisition consideration paid | ($31.0M) | ($21.0M) | ($22.0M) | ($32.0M) |
| Dividends paid | ($996.0M) | ($1.7B) | ($940.0M) | — |
| Distributions to noncontrolling and redeemable noncontrolling interests | ($34.0M) | ($53.0M) | ($35.0M) | — |
| Transactions involving noncontrolling interests | $28.0M | $19.0M | ($2.0M) | — |
| Repurchases of common stock | ($1.2B) | ($1.5B) | ($3.1B) | — |
| Amounts related to employee share plans | ($47.0M) | — | — | — |
| Net cash provided by (used in) financing activities | $596.0M | ($1.2B) | ($2.4B) | — |
| Effect of exchange rate changes on cash and cash equivalents, including restricted cash | $212.0M | ($143.0M) | $208.0M | — |
| Increase (decrease) in cash and cash equivalents, including restricted cash | $388.0M | ($2.6B) | $454.0M | — |
| Cash and cash equivalents and restricted cash at the beginning of year | $3.8B | $6.4B | $5.9B | — |
| Cash and cash equivalents and restricted cash at the end of year | $4.1B | $3.8B | — | — |
| Cash paid for interest (including finance leases) | $724.0M | $599.0M | $418.0M | — |
| Cash paid for income taxes | $831.0M | $960.0M | $959.0M | — |
| Cash and cash equivalents presented in the Consolidated Balance Sheets | $4.1B | $3.7B | $6.3B | — |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $1.3B | ($180.0M) | $2.8B | $1.2B |
| Depreciation, depletion, and amortization | $1.1B | $576.0M | — | $1.0B |
| Loss on impairments | $48.0M | $48.0M | — | — |
| Share-based compensation | $73.0M | $29.0M | $104.0M | $66.0M |
| Gain on disposals from businesses and long-lived assets, net | ($334.0M) | ($16.0M) | ($126.0M) | ($12.0M) |
| Deferred tax expense | $31.0M | ($160.0M) | $175.0M | $5.0M |
| Loss from equity method investments | $2.0M | $11.0M | ($17.0M) | $9.0M |
| Pension and other postretirement benefits net periodic benefit cost | $0 | $4.0M | $17.0M | $12.0M |
| Non-cash operating lease costs | $164.0M | $83.0M | $208.0M | $134.0M |
| Other items, net | $6.0M | $9.0M | $5.0M | $2.0M |
| Accounts receivable, net | ($1.8B) | ($478.0M) | ($1.9B) | ($1.4B) |
| Inventories | ($140.0M) | ($156.0M) | ($24.0M) | ($107.0M) |
| Accounts payable | $248.0M | ($287.0M) | ($264.0M) | ($58.0M) |
| Operating lease liabilities | ($167.0M) | ($86.0M) | ($226.0M) | ($153.0M) |
| Other assets | ($55.0M) | ($131.0M) | ($163.0M) | ($250.0M) |
| Other liabilities | $23.0M | $128.0M | $632.0M | $249.0M |
| Pension and other postretirement benefits contributions | ($21.0M) | ($10.0M) | ($30.0M) | ($20.0M) |
| Dividends received from equity method investments | $4.0M | — | — | — |
| Net cash used in operating activities | $513.0M | ($616.0M) | $2.7B | $719.0M |
| Purchases of property, plant and equipment, and intangibles | ($1.2B) | ($601.0M) | ($1.9B) | — |
| Acquisitions, net of cash acquired | ($1.1B) | ($126.0M) | ($3.1B) | ($648.0M) |
| Proceeds from divestitures | $1.7B | $6.0M | $52.0M | $37.0M |
| Proceeds from disposal of long-lived assets | $96.0M | $28.0M | $183.0M | $65.0M |
| Distributions received from equity method investments | $0 | $0 | $23.0M | $13.0M |
| Settlements of derivatives | ($33.0M) | ($24.0M) | ($72.0M) | ($33.0M) |
| Deferred divestiture consideration received | $0 | $0 | $40.0M | $38.0M |
| Other investing activities, net | $23.0M | ($5.0M) | $82.0M | $33.0M |
| Net cash used in investing activities | ($588.0M) | ($722.0M) | ($4.7B) | ($1.8B) |
| Proceeds from debt issuances | $1.6B | $1.2B | $7.8B | $4.5B |
| Payments on debt | ($1.1B) | ($207.0M) | ($3.7B) | ($3.4B) |
| Settlements of derivatives | ($40.0M) | ($15.0M) | $120.0M | $77.0M |
| Payments of finance lease obligations | ($73.0M) | ($37.0M) | ($73.0M) | ($46.0M) |
| Deferred and contingent acquisition consideration paid | ($18.0M) | ($12.0M) | ($28.0M) | ($13.0M) |
| Dividends paid | ($521.0M) | — | ($749.0M) | ($500.0M) |
| Distributions to noncontrolling and redeemable noncontrolling interests | ($23.0M) | ($15.0M) | ($31.0M) | ($22.0M) |
| Transactions involving noncontrolling interests | ($24.0M) | ($24.0M) | $2.0M | $2.0M |
| Repurchases of common stock | ($607.0M) | ($332.0M) | ($930.0M) | ($644.0M) |
| Amounts related to employee share plans | ($66.0M) | $2.0M | ($55.0M) | ($56.0M) |
| Net cash used in financing activities | ($949.0M) | $572.0M | $2.3B | ($12.0M) |
| Effect of exchange rate changes on cash and cash equivalents, including restricted cash | ($40.0M) | ($48.0M) | $205.0M | $205.0M |
| Decrease in cash and cash equivalents, including restricted cash | ($1.1B) | ($814.0M) | $529.0M | ($883.0M) |
| Cash and cash equivalents and restricted cash at the beginning of period | $4.1B | $4.1B | $3.8B | $3.8B |
| Cash and cash equivalents and restricted cash at the end of period | $3.1B | $3.3B | $4.3B | $2.9B |
| Cash paid for interest (including finance leases) | $335.0M | $160.0M | $494.0M | $251.0M |
| Cash paid for income taxes | $404.0M | $39.0M | $380.0M | $304.0M |
CRH Plc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.